Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-22-039464

SVP and General Counsel sold 7,000 shares at an average $274.18 ($1,919,231)

  • SVP and General Counsel acquired 7,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Option exercise +7,000 $91.79 $642,530 7,000 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −500 $267.88 $133,940 6,500 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −300 $268.99 $80,697 6,200 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −700 $270.25 $189,175 5,500 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −800 $271.27 $217,016 4,700 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −1,500 $272.74 $409,110 3,200 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −539 $273.48 $147,406 2,661 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −400 $274.70 $109,880 2,261 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −100 $275.24 $27,524 2,161 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −100 $276.40 $27,640 2,061 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −361 $277.77 $100,275 1,700 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −1,100 $279.46 $307,406 600 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −200 $280.41 $56,082 400 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −200 $281.79 $56,358 200 D
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Sale −200 $283.61 $56,722 0 D
Derivatives
Lynch Brian Joseph SVP and General Counsel 2022-12-23 Option exercise · Stock Option (Right to Buy) −7,000 25,000 D
Open-market sales · 7,000 sh · avg $274.18 · $1,919,231
Loading xslF345X03/doc4.xml…